HUP0100762A2 - Aromatáz-inhibítor alkalmazása férfiaknál kis androgén-ösztrogén arány és detrusor húgycső záróizom koordinációs zavar kezelésére, továbbá hím rágcsálókon végezhető, izomkoordinációs zavar vizsgálatára szolgáló eljárás - Google Patents
Aromatáz-inhibítor alkalmazása férfiaknál kis androgén-ösztrogén arány és detrusor húgycső záróizom koordinációs zavar kezelésére, továbbá hím rágcsálókon végezhető, izomkoordinációs zavar vizsgálatára szolgáló eljárásInfo
- Publication number
- HUP0100762A2 HUP0100762A2 HU0100762A HUP0100762A HUP0100762A2 HU P0100762 A2 HUP0100762 A2 HU P0100762A2 HU 0100762 A HU0100762 A HU 0100762A HU P0100762 A HUP0100762 A HU P0100762A HU P0100762 A2 HUP0100762 A2 HU P0100762A2
- Authority
- HU
- Hungary
- Prior art keywords
- dyssynergia
- men
- treatment
- aromatase inhibitor
- bladder
- Prior art date
Links
- 230000003247 decreasing effect Effects 0.000 title abstract 3
- 239000000262 estrogen Substances 0.000 title abstract 3
- 229940011871 estrogen Drugs 0.000 title abstract 3
- 229940122815 Aromatase inhibitor Drugs 0.000 title abstract 2
- 241000283984 Rodentia Species 0.000 title abstract 2
- 239000003886 aromatase inhibitor Substances 0.000 title abstract 2
- 210000005070 sphincter Anatomy 0.000 title abstract 2
- 206010003591 Ataxia Diseases 0.000 title 2
- 239000003098 androgen Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 210000002700 urine Anatomy 0.000 abstract 2
- 208000028484 Urethral disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000029142 excretion Effects 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 229940126601 medicinal product Drugs 0.000 abstract 1
- 230000027939 micturition Effects 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
- 210000003708 urethra Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Accommodation For Nursing Or Treatment Tables (AREA)
Abstract
A találmány tárgya aromatáz-inhibitor alkalmazása férfiaknál fellépői) detrusor húgycső záróizom koordinációs zavar, amely egy, a betegcsökkenő androgén-ösztrogén arányának következményeként jelentkezőhúgycső rendellenesség vagy ii) csökkenő androgén-ösztrogén aránykezelésére alkalmas gyógyszerkészítmény előállítására. A találmánykiterjed hím egyedeknél alkalmazható in vivo vizeletkiválasztásifunkció befolyásolására alkalmas vizsgálati eljárásra is, amelyneksorán a rágcsálót - az említett állapotba juttatják, - érzéstelenítik,- hólyagjába infúziós kanült vezetnek, amelyhez nyomásközvetítőt, ahúgycső távolabbi részébe vezetett és egy áramlásmérőhözcsatlakoztatott áramlási szondát csatlakoztatnak, - a hólyagba egyoldatot töltenek, amellyel vizeletürítést váltanak ki, és ahólyagnyomást és a vizeletáramlást regisztrálják az idő függvényében. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/989,447 US5972921A (en) | 1997-12-12 | 1997-12-12 | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men |
PCT/FI1998/000954 WO1999030708A2 (en) | 1997-12-12 | 1998-12-09 | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0100762A2 true HUP0100762A2 (hu) | 2001-08-28 |
HUP0100762A3 HUP0100762A3 (en) | 2002-12-28 |
Family
ID=25535123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0100762A HUP0100762A3 (en) | 1997-12-12 | 1998-12-09 | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
Country Status (17)
Country | Link |
---|---|
US (2) | US5972921A (hu) |
EP (1) | EP1043993B1 (hu) |
JP (1) | JP2002508322A (hu) |
KR (1) | KR20010032909A (hu) |
CN (1) | CN1281361A (hu) |
AT (1) | ATE235904T1 (hu) |
AU (1) | AU743196B2 (hu) |
BR (1) | BR9813534A (hu) |
CA (1) | CA2312347A1 (hu) |
DE (1) | DE69813025T2 (hu) |
EE (1) | EE200000346A (hu) |
ES (1) | ES2191358T3 (hu) |
HU (1) | HUP0100762A3 (hu) |
NO (1) | NO20002960L (hu) |
NZ (1) | NZ504632A (hu) |
PL (1) | PL341653A1 (hu) |
WO (1) | WO1999030708A2 (hu) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5972921A (en) | 1997-12-12 | 1999-10-26 | Hormos Medical Oy Ltd. | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men |
BR0013272B1 (pt) | 1999-08-13 | 2013-10-15 | Uso de um inibidor de aromatase esteroidal | |
US20030083342A1 (en) * | 2002-08-27 | 2003-05-01 | Steele Ronald Edward | Combination of organic compounds |
SK14612002A3 (sk) * | 2000-04-12 | 2003-05-02 | Novartis Ag | Farmaceutická kompozícia obsahujúca inhibítor aldosterónsyntázy prípadne v kombinácii s antagonistom AT1-receptora a jej použitie |
US6495534B2 (en) * | 2000-05-15 | 2002-12-17 | Pharmacia & Upjohn Spa | Stabilized aqueous suspensions for parenteral use |
FI20010905A0 (fi) * | 2001-05-02 | 2001-05-02 | Vetcare Oy | Uusi eläinlääke |
US6607755B2 (en) | 2001-06-21 | 2003-08-19 | Michael Donald Farley | Anti-aromatase pharmaceutical composition for controlling testosterone/estrone ratios |
US6931276B2 (en) * | 2002-04-29 | 2005-08-16 | Tomi Streng | Method and device for use in micturition studies |
US20040248989A1 (en) | 2003-06-05 | 2004-12-09 | Risto Santti | Method for the treatment or prevention of lower urinary tract symptoms |
EP1656129A4 (en) * | 2003-08-22 | 2009-03-11 | Univ Virginia | MTOR BLOCUS FOR PREVENTING HORMONE ADAPTIVE RESPONSE |
CN101448490A (zh) * | 2006-05-22 | 2009-06-03 | 霍尔莫斯医疗有限公司 | 治疗慢性非细菌性前列腺炎的选择性雌激素受体调节剂或者芳香酶抑制剂 |
BR112014005434B1 (pt) * | 2011-09-08 | 2021-01-05 | Novartis Ag | Composições farmacêuticas compreendendo inibidor da aromatase 4,4'-[fluoro-(1h-1,2,4triazol-1-il)metilemo]bisbenzonitrila e seu método de preparação |
CN102641502A (zh) * | 2012-04-25 | 2012-08-22 | 中国农业大学 | 芳香酶抑制剂的新用途 |
JP6545185B2 (ja) * | 2014-03-21 | 2019-07-17 | ドン・ワ・ファーム・カンパニー・リミテッドDong Wha Pharm. Co., Ltd. | インドナガコショウ抽出物を含む排尿障害の予防、治療及び改善用組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2273704B (en) * | 1992-12-16 | 1997-01-22 | Orion Yhtymae Oy | Triazolyl diaryl selective aromatase inhibiting compounds |
DE4435368A1 (de) | 1994-09-22 | 1996-03-28 | Schering Ag | Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann |
US5972921A (en) | 1997-12-12 | 1999-10-26 | Hormos Medical Oy Ltd. | Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men |
-
1997
- 1997-12-12 US US08/989,447 patent/US5972921A/en not_active Expired - Fee Related
-
1998
- 1998-09-12 US US09/581,128 patent/US6316431B1/en not_active Expired - Lifetime
- 1998-12-09 CN CN98812074A patent/CN1281361A/zh active Pending
- 1998-12-09 WO PCT/FI1998/000954 patent/WO1999030708A2/en not_active Application Discontinuation
- 1998-12-09 BR BR9813534-1A patent/BR9813534A/pt not_active IP Right Cessation
- 1998-12-09 PL PL98341653A patent/PL341653A1/xx unknown
- 1998-12-09 ES ES98958935T patent/ES2191358T3/es not_active Expired - Lifetime
- 1998-12-09 HU HU0100762A patent/HUP0100762A3/hu unknown
- 1998-12-09 NZ NZ504632A patent/NZ504632A/en unknown
- 1998-12-09 AU AU14897/99A patent/AU743196B2/en not_active Ceased
- 1998-12-09 EP EP98958935A patent/EP1043993B1/en not_active Expired - Lifetime
- 1998-12-09 EE EEP200000346A patent/EE200000346A/xx unknown
- 1998-12-09 KR KR1020007006244A patent/KR20010032909A/ko not_active Application Discontinuation
- 1998-12-09 AT AT98958935T patent/ATE235904T1/de not_active IP Right Cessation
- 1998-12-09 JP JP2000538691A patent/JP2002508322A/ja active Pending
- 1998-12-09 CA CA002312347A patent/CA2312347A1/en not_active Abandoned
- 1998-12-09 DE DE69813025T patent/DE69813025T2/de not_active Expired - Lifetime
-
2000
- 2000-06-09 NO NO20002960A patent/NO20002960L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CA2312347A1 (en) | 1999-06-24 |
EP1043993B1 (en) | 2003-04-02 |
JP2002508322A (ja) | 2002-03-19 |
NO20002960D0 (no) | 2000-06-09 |
BR9813534A (pt) | 2000-11-14 |
HUP0100762A3 (en) | 2002-12-28 |
US5972921A (en) | 1999-10-26 |
DE69813025T2 (de) | 2004-01-15 |
AU743196B2 (en) | 2002-01-24 |
DE69813025D1 (de) | 2003-05-08 |
ES2191358T3 (es) | 2003-09-01 |
US6316431B1 (en) | 2001-11-13 |
KR20010032909A (ko) | 2001-04-25 |
EP1043993A2 (en) | 2000-10-18 |
WO1999030708A3 (en) | 1999-08-19 |
NO20002960L (no) | 2000-08-14 |
ATE235904T1 (de) | 2003-04-15 |
WO1999030708A2 (en) | 1999-06-24 |
CN1281361A (zh) | 2001-01-24 |
PL341653A1 (en) | 2001-04-23 |
EE200000346A (et) | 2001-10-15 |
AU1489799A (en) | 1999-07-05 |
NZ504632A (en) | 2001-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0100762A2 (hu) | Aromatáz-inhibítor alkalmazása férfiaknál kis androgén-ösztrogén arány és detrusor húgycső záróizom koordinációs zavar kezelésére, továbbá hím rágcsálókon végezhető, izomkoordinációs zavar vizsgálatára szolgáló eljárás | |
US6494879B2 (en) | Treating urinary retention | |
CA2365447C (en) | Intravesicular balloon | |
Chang | Urodynamic studies in acupuncture for women with frequency, urgency and dysuria | |
US20020165427A1 (en) | Intravesicular device | |
JP2004535863A (ja) | 尿道プロファイル装置ならびにそのための方法。 | |
WO2006060248A3 (en) | Pressure and temperature monitoring balloon catheter | |
Gregersen et al. | Biomechanical wall properties and collagen content in the partially obstructed opossum esophagus | |
CN101991906A (zh) | 一种直肠球囊扩张导管 | |
ES2268683T3 (es) | Metodo y sistema para medicion, almacenamiento, recuperacion de la informacion almacenada y analisis en linea de datos urodinamicos. | |
Raz et al. | Carbon dioxide urethral pressure profile | |
Woodbury et al. | Constant pressure perfusion: a method to determine obstruction in the upper urinary tract | |
Johnson et al. | Transducer manometry and the effect of body position on anal canal pressures | |
JP7242688B2 (ja) | 尿流動態検査装置 | |
DE19530440C2 (de) | Rektalkatheter | |
Harrison | The urethral pressure profile | |
Plevnik | Model of the proximal urethra: measurement of the urethral stress profile | |
Hasegawa et al. | The effect of abdominal pressure on urinary flow rate | |
CN101658695B (zh) | 多气囊排便引流装置 | |
CN108903959A (zh) | 一种硅胶导管用于双腔膀胱临床测压方法 | |
Davis | Urinary tract obstruction: what has been learned about it, and what is still to be learned | |
CN208741720U (zh) | 一种带压力感受器的膀胱引流管 | |
CN205683082U (zh) | 一种前列腺及尿道测量导管 | |
Madersbacher | Combined pressure, flow, EMG and X-ray studies for the evaluation of neurogenic bladder disturbance: technique | |
Ronen | Measurements of urethral pressure profiles in the male horse |